Oral cancer, if detected early, has a 5-year survival rate of approximately 83%. Found late, the 5-year survival rate is poor: approximately 32%. Goldstein Dental Group offers VELscope Screening to help detect Oral Cancer early. VELscope Screening is newer technology and is presently the most widely used adjunctive device for the enhanced visualization of oral mucosal abnormalities, i.e. oral cancer. You do not need to rinse with a special liquid beforehand as you did in the past with Vizilite. VELscope has also been found to be more accurate and sensitive as a screening tool. It’s been studied in numerous studies worldwide. Goldstein Dental Group is proud to offer this diagnostic tool that can help save lives.
Schedule your appointment today.